Posted by Michael Wonder on 27 Mar 2024
PHARMAC funds new treatments for breast and blood cancer
27 March 2024 - PHARMAC is funding two new cancer treatments, one for advanced breast cancer (ribociclib succinate) and one for blood cancer (midostaurin).
Both will be available from 1 July 2024.
